The global benchmark for reliable health news and research
covering clinical trials, drugs, treatments and cures worldwide
|For 24/7 unlimited access...
or call us on: +43 (0)1 71 72 8 900 (Vienna)
Templeton Health is the global benchmark for the A-Z of reliable health news and research covering a wide range of illnesses and diseases.
Its extensive online platform and email services cover everything from the results of the most recent clinical trials to the real-time approval of new drugs and treatments worldwide.
Our service provides patients and healthcare professionals with personalised and indepth 24/7 treatment news, and extensive updates on various types of illnesses and diseases.
Patients are able to follow news and analysis on the treatments they are receiving, and on their alternatives, from reliable and reputable sources. Patients can also read up on the daily activities of the pharmaceutical companies behind those treatments.
Templeton Health is designed to provide invaluable information and research results to patients, their families and to healthcare professionals.
Our aim is to provide patients with a corporate level of health news and intelligence - the type of service that until now has only been made available to high level professionals in the pharmaceutical industry.
Our goal is to ensure that patients are alerted to new drugs, clinical trials, treatment options and the medical breakthroughs that have been made worldwide - as they happen.
Our pricing options are simple. You can gain unlimited access to Templeton Health by either of the following:
1. Making a single payment of £480 for a year's subscription.
2. Paying £60 a month for an ongoing subscription.
Both options give you your own personal Templeton Health account with full 24/7 access to the online platform.
You will have full access to all platform features and to the extensive email services. You can also request that drugs or treatments that are of special interest to you are added and tracked.
After signing up:
1. You will receive by email your login ID and password within 3 hours.
2. The email will include a weblink with a 10 minute video demo explaining how to most effectively use your Templeton Health account.
3. You will be asked in the email if you have any special information requests.
The technology that we have developed behind our service ensures that Templeton Health is quick and user-friendly. Whether you are a patient or a healthcare professional, it provides you with the exact customised information you require.
Our service provides detailed statistical analysis enabling you to discover which drugs and treatments are being provided to combat illnesses and diseases.
Detailed news, information and intelligence are provided on the pharmaceutical companies developing and producing drugs.
Templeton Health tracks health news and research worldwide. It is not limited to one continent or to one language.
You are able to request that drugs and treatments of specific interest to you personally are added and tracked by our service.
Until now, there has not been a service in existence that provides top-notch, comprehensive and ground-breaking global health news for patients and their families.
Neither has there been a global service that provides automated updates on the most recent clinical trials, treatments and cures that are of specific and personal interest to patients.
We believe that there should be. This is why we have developed our Templeton Health intelligence platform.
Some might ask why patients would want access to the same level of superior news, information and research that is available to healthcare and pharmaceutical professionals.
In response we believe that it is a mixture of opportunity, necessity and freedom of choice.
Templeton Health has been designed to provide you with the tools, and the specialist knowledge, to make you better informed.
In doing so, we intend that Templeton Health will enable patients to take a more active role when making important decisions about their treatment.
To do our best to help save lives worldwide.